Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Cherry
Characterization of Duvelisib in Patients With Refractory Marginal Zone Lymphoma: Data From the Phase 2 Dynamo Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Ly-4, a New Locus Determining a Lymphocyte Cell-Surface Alloantigen in Mice
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Copanlisib Treatment of Patients With Relapsed or Refractory Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Umbralisib Monotherapy Demonstrates Efficacy and Safety in Patients With Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Registration Directed Phase 2 Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase 2 Trial of Rituximab and Bortezomib in Patients With Relapsed or Refractory Mantle Cell and Follicular Lymphoma
Cancer
Cancer Research
Oncology
Elara: A Phase 2 Trial Investigating the Efficacy and Safety of Tisagenlecleucel in Adult Patients With Refractory/Relapsed Follicular Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Obinutuzumab Therapy in Patients With Marginal Zone and Mantle Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Splenic Marginal Zone Lymphoma
Phase Iiib Study of Lenalidomide Plus Rituximab Followed by Maintenance in Relapsed or Refractory Nhl: Analysis of Marginal Zone Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Effect of Dose Modifications on Response to Duvelisib in Patients With Relapsed/Refractory CLL/SLL in the Duo Trial
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Marginal Zone B-Cell Lymphoma
